BioSig Technologies, Inc.
BSGM
$0.60
-$0.136-18.48%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.28M | -17.93M | -25.11M | -29.04M | -29.95M |
| Total Depreciation and Amortization | 603.00K | 616.00K | 654.00K | 654.00K | 696.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.70M | 9.32M | 9.51M | 10.31M | 9.94M |
| Change in Net Operating Assets | -4.25M | -1.57M | 1.97M | 769.00K | 829.00K |
| Cash from Operations | -7.23M | -9.57M | -12.98M | -17.31M | -18.49M |
| Capital Expenditure | -4.00K | -64.00K | -141.00K | -186.00K | -240.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.00K | -64.00K | -141.00K | -186.00K | -240.00K |
| Total Debt Issued | 500.00K | 500.00K | 500.00K | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.96M | 9.58M | 9.66M | 15.36M | 16.26M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 401.00K | 1.97M | 1.97M | 1.97M |
| Cash from Financing | 7.46M | 10.48M | 12.12M | 17.33M | 18.23M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 226.00K | 852.00K | -996.00K | -167.00K | -498.00K |
